Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trialAchim Rittmeyer, David R. Gandara, Fabrice Barlési et al.|The Lancet|2016Cited by 4.8k
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerLeora Horn, Stephen V. Liu, Sivuonthanh Lam et al.|New England Journal of Medicine|2018Cited by 3.5k
Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled TrialsHerbert I. Hurwitz, Josep Tabernero, Niall C. Tebbutt et al.|The Oncologist|2013Cited by 235
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studiesJames T. Cassidy, Ulrich‐Peter Rohr, Leonard B. Saltz et al.|Journal of Cancer Research and Clinical Oncology|2009Cited by 160
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade GliomaTimothy F. Cloughesy, Michael A. Vogelbaum, Kevin Petrecca et al.|JAMA Oncology|2020Cited by 141